- Home
- FLGT vs IMOS Comparison
FLGT vs IMOS Comparison
Compare FLGT & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- IMOS
- Stock Information
- Founded
- FLGT 2011
- IMOS 1997
- Country
- FLGT United States
- IMOS Taiwan
- Employees
- FLGT N/A
- IMOS N/A
- Industry
- FLGT Medical Specialities
- IMOS Semiconductors
- Sector
- FLGT Health Care
- IMOS Technology
- Exchange
- FLGT Nasdaq
- IMOS Nasdaq
- Market Cap
- FLGT 697.3M
- IMOS 713.8M
- IPO Year
- FLGT 2016
- IMOS N/A
- Fundamental
- Price
- FLGT $22.36
- IMOS $22.06
- Analyst Decision
- FLGT Buy
- IMOS
- Analyst Count
- FLGT 3
- IMOS 0
- Target Price
- FLGT $25.33
- IMOS N/A
- AVG Volume (30 Days)
- FLGT 199.8K
- IMOS 11.8K
- Earning Date
- FLGT 11-07-2025
- IMOS 11-11-2025
- Dividend Yield
- FLGT N/A
- IMOS 2.96%
- EPS Growth
- FLGT N/A
- IMOS N/A
- EPS
- FLGT N/A
- IMOS 0.01
- Revenue
- FLGT $303,223,000.00
- IMOS $777,452,000.00
- Revenue This Year
- FLGT $15.19
- IMOS $3.76
- Revenue Next Year
- FLGT $10.58
- IMOS $5.93
- P/E Ratio
- FLGT N/A
- IMOS $125.22
- Revenue Growth
- FLGT 4.31
- IMOS 0.89
- 52 Week Low
- FLGT $14.57
- IMOS $12.78
- 52 Week High
- FLGT $24.64
- IMOS $23.32
- Technical
- Relative Strength Index (RSI)
- FLGT 45.76
- IMOS 58.18
- Support Level
- FLGT $22.06
- IMOS $20.45
- Resistance Level
- FLGT $23.15
- IMOS $22.40
- Average True Range (ATR)
- FLGT 0.71
- IMOS 0.55
- MACD
- FLGT -0.12
- IMOS -0.01
- Stochastic Oscillator
- FLGT 17.05
- IMOS 59.75
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.